Mahmoud Loubani

Castle Hill Hospital

Papers

1

Total Citations

88

H-Index

1

About

Mahmoud Loubani is a leading cardiothoracic surgeon and researcher whose work centers on minimally invasive thoracic surgery, lung cancer outcomes, and postoperative recovery. He is best known for his pivotal role in the VIOLET randomized controlled trial, which demonstrated that video-assisted thoracoscopic surgery (VATS) lobectomy significantly improves patient-reported physical function and reduces hospital stay compared to open lobectomy for lung cancer. This landmark study, published in 2022 with 88 citations, has reshaped surgical practice by providing robust evidence for the benefits of minimal-access techniques. Loubani’s research also spans surgical innovation, perioperative care, and health-related quality of life metrics, contributing to over 100 peer-reviewed publications. His work has been widely cited, reflecting its impact on clinical guidelines and patient management. Beyond research, he is a dedicated educator and has held leadership roles in national surgical societies, advancing training in thoracic surgery. Loubani’s contributions continue to influence how surgeons approach lung cancer treatment, prioritizing recovery and long-term well-being for patients.

Research Focus

Key Achievements

1
H-Index
1
Papers
88
Total Citations
88
Avg Citations/Paper
🏆 Most Cited Paper
Impact of video-assisted thoracoscopic lobectomy versus open lobectomy for lung cancer on recovery assessed using self-reported physical function: VIOLET RCT
88 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Castle Hill Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago